Skip to main navigation Skip to search Skip to main content

Effectiveness and Safety of Combining Tofacitinib with a Biologic in Patients with Refractory Inflammatory Bowel Diseases

  • Quazim A. Alayo
  • , Aava Khatiwada
  • , Anish Patel
  • , Maria Zulfiqar
  • , Anas Gremida
  • , Alexandra Gutierrez
  • , Richard P. Rood
  • , Matthew A. Ciorba
  • , George Christophi
  • , Parakkal Deepak*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

34 Scopus citations
Original languageEnglish
Pages (from-to)1698-1702
Number of pages5
JournalInflammatory Bowel Diseases
Volume27
Issue number10
DOIs
StatePublished - 1 Oct 2021
Externally publishedYes

Keywords

  • biologics
  • combination therapy
  • inflammatory bowel disease
  • tofacitinib

Fingerprint

Dive into the research topics of 'Effectiveness and Safety of Combining Tofacitinib with a Biologic in Patients with Refractory Inflammatory Bowel Diseases'. Together they form a unique fingerprint.

Cite this